Early Diagnosis of Axial Spondyloarthritis Is Associated With Less Long-Term Spinal Structural Damage: A Longitudinal Analysis of the Swiss Clinical Quality Management in Rheumatic Diseases Registry.
Annik Steimer, Jonas Brändli, Mauro Bachmann, Andrea Götschi, Claudia L Rodrigues, Michael J Nissen, Burkhard Möller, Kristina Bürki, Martin Wendiggensen, Simon Grosswiler, Michael Andor, Diana Dan, Frauke Förger, Sabine Adler, Diego Kyburz, Oliver Distler, Raphael Micheroli, Sofia Ramiro, Adrian Ciurea
{"title":"Early Diagnosis of Axial Spondyloarthritis Is Associated With Less Long-Term Spinal Structural Damage: A Longitudinal Analysis of the Swiss Clinical Quality Management in Rheumatic Diseases Registry.","authors":"Annik Steimer, Jonas Brändli, Mauro Bachmann, Andrea Götschi, Claudia L Rodrigues, Michael J Nissen, Burkhard Möller, Kristina Bürki, Martin Wendiggensen, Simon Grosswiler, Michael Andor, Diana Dan, Frauke Förger, Sabine Adler, Diego Kyburz, Oliver Distler, Raphael Micheroli, Sofia Ramiro, Adrian Ciurea","doi":"10.1002/art.70346","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>The Assessment of SpondyloArthritis international Society recently defined early axial spondyloarthritis (axSpA) as a duration of two years or less of axial symptoms. Previous studies have shown no significant difference in short-term outcomes between patients with early and established axSpA treated with biologic/targeted synthetic disease-modifying antirheumatic drugs. To evaluate long-term outcomes, we compared spinal radiographic progression between patients with early and established axSpA who were observed under standard of care treatment in a large Swiss cohort.</p><p><strong>Methods: </strong>Patients with axSpA who had at least two sets of spinal radiographs between 2004 and 2024 in the Swiss Clinical Quality Management registry were scored with the modified Stoke Ankylosing Spondylitis Spinal Score (mSASSS) by two readers and an adjudicator in case of disagreement. Longitudinal radiographic progression between early and established axSpA was compared (from the time of diagnosis) using a four-parametric logistic model, accounting for the nonlinear progression of mSASSS.</p><p><strong>Results: </strong>Among 376 patients with 1,181 sets of radiographs, 138 patients had early and 238 had established axSpA. Baseline characteristics were similar between the two groups, with a male predominance (61%) and a high prevalence of HLA-B27 positivity (69%). Mean (SD) overall follow-up was 11.5 (8.6) years. Patients with early axSpA exhibited a lower long-term mSASSS (-3.85 mSASSS units, 95% confidence interval [CI] -7.28 to -0.42) compared with established axSpA. This difference became evident 10 to 15 years after diagnosis. The results remained statistically significant after adjustment for baseline radiographic damage (-5.70 mSASSS units, 95% CI -9.31 to -2.09).</p><p><strong>Conclusion: </strong>Early diagnosis of axSpA is associated with lower long-term spinal structural damage.</p>","PeriodicalId":129,"journal":{"name":"Arthritis & Rheumatology","volume":" ","pages":""},"PeriodicalIF":9.9000,"publicationDate":"2026-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Arthritis & Rheumatology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1002/art.70346","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"RHEUMATOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: The Assessment of SpondyloArthritis international Society recently defined early axial spondyloarthritis (axSpA) as a duration of two years or less of axial symptoms. Previous studies have shown no significant difference in short-term outcomes between patients with early and established axSpA treated with biologic/targeted synthetic disease-modifying antirheumatic drugs. To evaluate long-term outcomes, we compared spinal radiographic progression between patients with early and established axSpA who were observed under standard of care treatment in a large Swiss cohort.
Methods: Patients with axSpA who had at least two sets of spinal radiographs between 2004 and 2024 in the Swiss Clinical Quality Management registry were scored with the modified Stoke Ankylosing Spondylitis Spinal Score (mSASSS) by two readers and an adjudicator in case of disagreement. Longitudinal radiographic progression between early and established axSpA was compared (from the time of diagnosis) using a four-parametric logistic model, accounting for the nonlinear progression of mSASSS.
Results: Among 376 patients with 1,181 sets of radiographs, 138 patients had early and 238 had established axSpA. Baseline characteristics were similar between the two groups, with a male predominance (61%) and a high prevalence of HLA-B27 positivity (69%). Mean (SD) overall follow-up was 11.5 (8.6) years. Patients with early axSpA exhibited a lower long-term mSASSS (-3.85 mSASSS units, 95% confidence interval [CI] -7.28 to -0.42) compared with established axSpA. This difference became evident 10 to 15 years after diagnosis. The results remained statistically significant after adjustment for baseline radiographic damage (-5.70 mSASSS units, 95% CI -9.31 to -2.09).
Conclusion: Early diagnosis of axSpA is associated with lower long-term spinal structural damage.
期刊介绍:
Arthritis & Rheumatology is the official journal of the American College of Rheumatology and focuses on the natural history, pathophysiology, treatment, and outcome of rheumatic diseases. It is a peer-reviewed publication that aims to provide the highest quality basic and clinical research in this field. The journal covers a wide range of investigative areas and also includes review articles, editorials, and educational material for researchers and clinicians. Being recognized as a leading research journal in rheumatology, Arthritis & Rheumatology serves the global community of rheumatology investigators and clinicians.